Tag: Ivig side effects

A 2018 survey by the Immune Deficiency Foundation found that 98% of patients using IVIG experienced side effects, highlighting the critical need to know **what to monitor while giving IVIG**. Careful observation is essential to prevent, detect, and manage potential adverse reactions during infusion.

Reports from clinical studies indicate that diarrhea is a recognized and sometimes frequent adverse event associated with intravenous immunoglobulin (IVIG) therapy, with some studies citing an incidence as high as 28%. Patients should understand that IVIG can cause diarrhea, recognize potential risk factors, and know how to manage this common side effect effectively.

While generally considered safe, fewer than 5% of people who receive Intravenous Immunoglobulin (IVIG) experience moderate to severe side effects [1.2.1]. The question of whether *Is IVIG a high risk medication?* is complex, balancing its life-saving benefits against potential adverse reactions.

Pancreatitis is an exceptionally rare but recognized adverse effect of intravenous immunoglobulin (IVIG) therapy, with only a few documented cases reported in the medical literature. Although generally considered a safe and effective treatment for various autoimmune and immunodeficiency disorders, patients and providers should be aware of this potential, albeit uncommon, complication.